Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01746238
Title Bevacizumab/Doxorubicin/Radiation for Sarcoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Massachusetts General Hospital
Indications

sarcoma

Therapies

Bevacizumab + Doxorubicin

Age Groups: adult
Covered Countries USA


No variant requirements are available.